Abstract
Cytokine receptors have different signaling requirements which ultimately lead to various physiological responses. In an effort to precisely characterize the molecular determinants involved in the proliferative response mediated by cytokines, we examine dose-dependent proliferation of the βc (GM-CSF, IL-3, IL-5) and homodimeric (G-CSF, TPO) cytokine receptors. Here we report that all cytokine receptors tested activate mostly STAT3 and STAT5. While STAT3 had a positive effect on βc cytokine receptor dependent proliferation, STAT5 was strongly inhibitory. Similarly, G-CSF and TPO lead to activation of STAT3 and STAT5 but, unlike the βc cytokine receptors, both stimulated cellular growth. On the other hand, Ras activation was necessary for all receptor mediated proliferation with the exception of G-CSF R. Truncated mutants of the receptors intracellular domains were used to delineate the functional domains involved in JAK/STAT and Ras activation linked to cellular growth. For instance, we revealed a critical role for the specific alpha subunit of the βc receptors in triggering receptor activation, STAT3 stimulation and proliferation, while Ras activation originates from the distal intracellular portion of the βc subunit. Finally, we showed that proximal STAT activation is the triggering event of G-CSF and TPO receptor function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adachi T, Pazdrak K, Stafford S, Alam R . 1999a J. Immunol. 162: 1496–1501
Adachi T, Stafford S, Sur S, Alam R . 1999b J. Immunol. 163: 939–946
Barge RM, de Koning JP, Pouwels K, Dong F, Lowenberg B, Touw IP . 1996 Blood 87: 2148–2153
Barry SC, Korpelainen E, Sun Q, Stomski FC, Moretti PA, Wakao H, D'Andrea RJ, Vadas MA, Lopez AF, Goodall GJ . 1997 Blood 89: 842–852
Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, Franklin RA, Oberhaus SM, Steelman LS, McCubrey JA . 1999 Leukemia 13: 1109–1166
Bonfini L, Migliaccio E, Pelicci G, Lanfrancone L, Pelicci PG . 1996 Trends Biochem. Sci. 21: 257–261
Bourette RP, Myles GM, Carlberg K, Chen AR, Rohrschneider LR . 1995 Cell Growth Differ. 6: 631–645
Brauner-Osborne H, Brann MR . 1996 Eur. J. Pharmacol. 295: 93–102
Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell Jr JE . 1998 Mol. Cell. Biol. 18: 2553–2558
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell Jr JE . 1999 Cell 98: 295–303
Burstein ES, Brauner-Osborne H, Spalding TA, Conklin BR, Brann MR . 1997 J Neurochem. 68: 525–533
Burstein ES, Spalding TA, Hill-Eubanks D, Brann MR . 1995 J. Biol. Chem. 270: 3141–3146
Chakraborty A, Dyer KF, Cascio M, Mietzner TA, Tweardy DJ . 1999 Blood 93: 15–24
Darnell Jr JE . 1997 Science 277: 1630–1635
de Koning JP, Schelen AM, Dong F, van Buitenen C, Burgering BM, Bos JL, Lowenberg B, Touw IP . 1996 Blood 87: 132–140
de Koning JP, Soede-Bobok AA, Schelen AM, Smith L, van Leeuwen D, Santini V, Burgering BM, Bos JL, Lowenberg B, Touw IP . 1998 Blood 91: 1924–1933
Dorsch M, Fan PD, Danial NN, Rothman PB, Goff SP . 1997 J. Exp. Med. 186: 1947–1955
Downward J . 1996 Cancer Surv. 27: 87–100
Doyle SE, Gasson JC . 1998 Blood 92: 867–876
Drachman JG, Kaushansky K . 1997 Proc. Natl. Acad. Sci. USA 94: 2350–2355
Gurney AL, Wong SC, Henzel WJ, de Sauvage FJ . 1995 Proc. Natl. Acad. Sci. USA 92: 5292–5296
Haque SJ, Harbor P, Tabrizi M, Yi T, Williams BR . 1998 J. Biol. Chem. 273: 33893–33896
Ihle JN . 1996 Bioessays 18: 95–98
Ilaria RL, Hawley RG, Van Etten RA . 1999 Blood 93: 4154–4166
Inhorn RC, Carlesso N, Durstin M, Frank DA, Griffin JD . 1995 Proc. Natl. Acad. Sci. USA 92: 8665–8669
Kasper B, Tidow N, Welte K . 1999 Int. J. Hematol. 70: 241–247
Kinoshita T, Yokota T, Arai K, Miyajima A . 1995 EMBO. J. 14: 266–275
Kouro T, Kikuchi Y, Kanazawa H, Hirokawa K, Harada N, Shiiba M, Wakao H, Takaki S, Takatsu K . 1996 Int. Immunol. 8: 237–245
Levy DE, Gilliland DG . 2000 Oncogene 19: 2505–2510
Lia F, Rajotte D, Clark SC, Hoang T . 1996 J. Biol. Chem. 271: 28287–28293
Luoh SM, Stefanich E, Solar G, Steinmetz H, Lipari T, Pestina TI, Jackson CW, de Sauvage FJ . 2000 Mol. Cell. Biol. 20: 507–515
Matsuguchi T, Zhao Y, Lilly MB, Kraft AS . 1997 J. Biol. Chem. 272: 17450–17459
Mattingly RR, Sorisky A, Brann MR, Macara IG . 1994 Mol. Cell. Biol. 14: 7943–7952
Morita H, Tahara T, Matsumoto A, Kato T, Miyazaki H, Ohashi H . 1996 FEBS Lett. 395: 228–234
Muto A, Watanabe S, Itoh T, Miyajima A, Yokota T, Arai K . 1995 J. Allergy Clin. Immunol. 96: 1100–1114
Nicholson SE, Novak U, Ziegler SF, Layton JE . 1995 Blood 86: 3698–3704
Patel BK, Wang LM, Lee CC, Taylor WG, Pierce JH, LaRochelle WJ . 1996 J. Biol. Chem. 271: 22175–22182
Piu F, Aronheim A, Katz S, Karin M . 2001 Mol. Cell. Biol. 21: 3012–3024
Porteu F, Rouyez MC, Cocault L, Benit L, Charon M, Picard F, Gisselbrecht S, Souyri M, Dusanter-Fourt I . 1996 Mol. Cell. Biol. 16: 2473–2482
Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin JD, Ihle JN . 1994 Mol. Cell. Biol. 14: 4335–4341
Rausch O, Marshall CJ . 1999 J. Biol. Chem. 274: 4096–4105
Rausch O, Marshall CJ . 1997 Mol. Cell. Biol. 17: 1170–1179
Ronco LV, Silverman SL, Wong SG, Slamon DJ, Park LS, Gasson JC . 1994 J. Biol. Chem. 269: 277–283
Rouyez MC, Boucheron C, Gisselbrecht S, Dusanter-Fourt I, Porteu F . 1997 Mol. Cell. Biol. 17: 4991–5000
Silvennoinen O, Saharinen P, Paukku K, Takaluoma K, Kovanen P . 1997 APMIS 105: 497–509
Smith A, Metcalf D, Nicola NA . 1997 EMBO. J. 16: 451–464
Takaki S, Murata Y, Kitamura T, Miyajima A, Tominaga A, Takatsu K . 1993 J. Exp. Med. 177: 1523–1529
Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S, Jove R . 1999 Mol. Cell. Biol. 19: 7519–7528
Ward AC, Monkhouse JL, Csar XF, Touw IP, Bello PA . 1998 Biochem. Biophys. Res. Commun. 251: 117–123
Watanabe S, Arai KI . 1996 Curr. Opin. Genet. Dev. 6: 587–596
Weiss M, Yokoyama C, Shikama Y, Naugle C, Druker B, Sieff CA . 1993 Blood 82: 3298–3306
Wilks AF, Oates AC . 1996 Cancer Surv. 27: 139–163
Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN . 1993 Cell 74: 227–236
Yoshimura A, Misawa H . 1998 Curr. Opin. Hematol. 5: 171–176
Acknowledgements
We are thankful to B Groner for providing the STAT6 construct, J Layton for the human G-CSF receptor and A Miyajima for the human GM-CSF receptor alpha and βc subunits. We are grateful to I Macara for RasN17 and J Pessin for the Sos1 constuct. We wish to acknowledge M Brann for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Piu, F., Magnani, M. & Ader, M. Dissection of the cytoplasmic domains of cytokine receptors involved in STAT and Ras dependent proliferation. Oncogene 21, 3579–3591 (2002). https://doi.org/10.1038/sj.onc.1205444
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205444